Talus Bio Funding & Investors
Seattle, WA
Talus Bio is a drug discovery biotech startup working on drug development for gene regulators. The company is building a data-enabled platform that focuses primarily on small molecule drug development in oncology.
talus.bioTotal Amount Raised: $27,781,502
Talus Bio Funding Rounds
Seed
$11,200,000
Seed Investors
Two Bear CapitalWRF CapitalY Combinator Continuity FundBoxOne VenturesFundersClubNFXRolling Bay VenturesGrant
$2,000,000
Grant Investors
NCATSGrant
$705,876
Grant Investors
National Institutes of Health (NIH)NCATSGrant
$2,294,310
Grant Investors
Andy Hill Cancer Research Endowment (CARE) FundGrant
$2,000,000
Grant Investors
National Cancer Institute (NCI)Grant
$788,867
Grant Investors
National Institutes of Health (NIH)National Cancer Institute (NCI)Seed
$7,149,118
Seed Investors
NFXNorth South VenturesGrant
$255,831
Grant Investors
National Science Foundation (NSF)Pre Seed
$1,387,500
Pre Seed Investors
Fifty YearsBoom Capital Ventures
Funding info provided by Diffbot.